The Scientist - Home

Along the way, she bumps into an old friend and current colleague, a radiologist with whom she shared an early-morning physics class in her undergraduate days; he is now a nuclear science professor at the school. Reliving old times and casually discussing their disparate research, they settle in a nearby alcove, one of several "interaction spaces" that dot the architecture of the building. An off-hand remark by her friend implants

Beatrice Mintz, a senior member of the Institute for Cancer Research at the Fox Chase Cancer Center in Philadelphia, was presented with the John Scott Award during a reception on November 18 at the American Philosophical Society in Philadelphia. The prize was set up in the early 1800s by John Scott, a Scottish druggist, who entrusted the administration of the award--originally $20 and an inscribed copper medal--to the city of Phila

In a Nov. 7, 1994, letter, Marvin Cassman, acting director of the National Institute of General Medical Sciences (NIGMS), informed NIGMS grantees that the institute is "making special efforts" to fund applications that contain risky or unorthodox ideas or methods. Specifically, these would be applications that contain ideas that challenge current dogma; include experimental approaches that have inherent or unavoidable elements of ri

Among scientists, Joachim Messing, in his excellent commentary (The Scientist, June 27, 1994, page 13), made the case for supporting many small, rather than a few large, projects. Some excellent suggestions on improvements have also been proposed by Jose M. Musacchio, though he, too, refrains from suggesting major changes in the peer-review system (FASEB Journal, 8:679-83, 1994). Of all the information recently brought out on spons

Cancer Researcher For 'Crazy Ideas' AUTHOR: NEERAJA SANKARAN, pp.23 AUTHOR:BARBARA SPECTOR, pp.23 DATE: December 12, 1994 Cancer Researcher For 'Crazy Ideas' Author : NEERAJA SANKARAN, pp.23 Date: December 12, 1994 Beatrice Mintz, a senior member of the Institute for Cancer Research at the Fox Chase Cancer Center in Philadelphia, was presented with the John Scott Award during a reception on November 18 at the American Philosophi

But, just as antibodies are finding increasing utility in cell biology, a new Food and Drug Administration classification for those products with clinical utility may affect researchers' access to the important technology (see accompanying story). Monoclonal History MAbs were born in 1975, when Georges Kohler and Cesar Milstein at the Medical Research Council Laboratories in Cambridge, England, fused two types of cells to form a hy

Date : December 12, 1994 Back To: Pharmaceutical Companies Stress Innovative Research For Success The Pharmaceutical Research and Manufacturers of America (PhRMA), a trade association of research-based pharmaceutical companies, reports an almost 15 percent reduction in the overall work force in the past two to three years, with current employment totaling 266,000. 19900 19912,700 19925,950 199324,850 199412,880 TOTAL46,380 Ma

Sidebar:A New Look For Summary Statements Sidebar: What is Triage? The expanded use of triage--under which certain grant applications deemed to be "noncompetitive" (NC) are not discussed in study sections--by the National Institutes of Health Division of Research Grants (DRG) has met with enthusiasic response from many NIH administrators. The new system, however, has engendered controversy in the extramural community. NIH welcomes

The moratorium on human embryo research coincided with the Republican presidencies of Ronald Reagan and George Bush. Both administrations opposed abortion, with support from some conservative political and religious groups, based on the view that human life begins when the ovum is fertilized and that the resulting embryo has legal rights to protection similar to those of an infant, child, or adult. In recent years, the Bush administ

Back To: Science Community Gives Mixed Reviews To 'Triage' The National Institutes of Health announced in the September 23 NIH Guide for Grants and Contracts that it will extend its use of a triage system to all investigator-initiated research grant (R01) and "FIRST Award" (First Independent Research Support and Transition Award, R29) applications submitted for October/November 1, 1994 receipt dates and reviewed by the NIH

Back To:Science Community Gives Mixed Review To 'Triage' Summary statements for National Institutes of Health grant applications (often referred to as "pink sheets," although they have not been printed on pink paper since 1991) will be formatted differently from now on: Summary statements will consist primarily of the individual reviewers' critiques. Scientific review administrators (SRAs) will write summaries of the s

Bassam Shakhashiri, a professor of chemistry at the University of Wisconsin, Madison, who was assistant director for science and engineering education at the National Science Foundation from 1984 to 1990, contends that industry involvement in this effort is more than a welcome contribution; it is a necessity. "The business community must be involved intimately in the science education reform arena because they have expertise that ac